Compare ABCL & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | MLKN |
|---|---|---|
| Founded | 2012 | 1905 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2020 | 1994 |
| Metric | ABCL | MLKN |
|---|---|---|
| Price | $9.44 | $24.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.40 | N/A |
| AVG Volume (30 Days) | ★ 6.1M | 660.2K |
| Earning Date | 05-11-2026 | 03-25-2026 |
| Dividend Yield | N/A | ★ 4.71% |
| EPS Growth | 10.91 | ★ 344.44 |
| EPS | N/A | ★ 1.32 |
| Revenue | $75,128,000.00 | ★ $3,841,700,000.00 |
| Revenue This Year | N/A | $5.94 |
| Revenue Next Year | $21.85 | $3.78 |
| P/E Ratio | ★ N/A | $18.28 |
| Revenue Growth | ★ 160.56 | 4.68 |
| 52 Week Low | $2.75 | $13.77 |
| 52 Week High | $10.01 | $24.71 |
| Indicator | ABCL | MLKN |
|---|---|---|
| Relative Strength Index (RSI) | 77.04 | 63.91 |
| Support Level | $3.38 | $18.05 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.51 | 0.81 |
| MACD | 0.29 | -0.00 |
| Stochastic Oscillator | 87.97 | 79.83 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.